US Patent 10093983 Estrogen receptor mutations and uses thereof
Patent 10093983 was granted and assigned to Foundation Medicine on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+66 characters)
Article
Patent abstract
Novel mutant ESR1 molecules and uses are disclosed.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Doron Lipson0
Garrett Michael Frampton0
Gary Palmer0
Jeffrey S. Ross0
Maureen T. Cronin0
Philip James Stephens0
Roman Yelensky0
Vincent A. Miller0
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100939830
Date of Patent
October 9, 2018
0Patent Application Number
147533970
Date Filed
June 29, 2015
0Patent Primary Examiner
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10093983 Estrogen receptor mutations and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10093983
Date of patent
October 9, 2018
Patent application number
14753397
Date Filed
June 29, 2015
Patent primary examiner
Find more entities like US Patent 10093983 Estrogen receptor mutations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.